Rosenbaum Jay D. Biogen Inc. Transaction History

Rosenbaum Jay D.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$219.29 - $241.72 $388,362 - $428,086	-1,771 Closed	0 $0
Q1 2019 Apr 17, 2019	SELL	$216.71 - $338.96 $6,501 - $10,168	-30 Reduced 1.67%	1,771 $419,000
Q4 2018 Jan 14, 2019	SELL	$278.5 - $352.75 $12,254 - $15,521	-44 Reduced 2.38%	1,801 $542,000
Q3 2018 Oct 23, 2018	SELL	$293.51 - $383.83 $67,507 - $88,280	-230 Reduced 11.08%	1,845 $652,000
Q2 2018 Jul 26, 2018	SELL	$257.52 - $306.91 $13,906 - $16,573	-54 Reduced 2.54%	2,075 $602,000
Q1 2018 Apr 19, 2018	BUY	$260.13 - $367.91 $6,503 - $9,197	25 Added 1.19%	2,129 $583,000
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $591,539 - $693,667	2,104	2,104 $659,000

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Rosenbaum Jay D., based on Form 13F filings with the SEC.

Stay updated on Rosenbaum Jay D. with notifications on news.